The largest database of trusted experimental protocols

705 it electronic

Manufactured by Omron
Sourced in Netherlands

The OMRON 705 IT electronic is a device used for measuring blood pressure. It provides digital readouts of systolic and diastolic blood pressure measurements, as well as pulse rate.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using 705 it electronic

1

Automated BP Measurement Adjustment

Check if the same lab product or an alternative is used in the 5 most similar protocols
BP measurements were available for 475,166 participants. During the baseline assessment center visit, two automated readings were taken a few moments apart using an OMRON 705 IT electronic BP monitor (OMRON Healthcare Europe, Hoofddorp, Netherlands). An average value of the two readings was calculated and then adjusted for BP-lowering medication by adding 15 mm Hg, as described previously.17 (link) This antihypertensive medication–adjusted phenotype was used in all analyses. SBP, diastolic blood pressure (DBP), and pulse pressure (PP) were analyzed independently in order to understand the impact of different aspects of BP on IOP or glaucoma.
+ Open protocol
+ Expand
2

Cardiovascular Risk Factor Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
Systolic and diastolic blood pressure were measured twice at the assessment center during the inclusion consultation using an automated blood pressure device (OMRON 705IT electronic blood pressure monitor [OMRON Healthcare Europe]). Alternatively, measurements were taken manually with a sphygmomanometer and stethoscope in cases in which the blood pressure device failed or the largest cuff did not fit the individual's arm. 28 Hypertension was defined as having a systolic blood pressure of at least 140 mm Hg and/or a diastolic blood pressure of at least 90 mm Hg. This definition aligns with the guidelines set by the European Society of Cardiology and includes cases managed with antihypertensive drugs or diagnosed by a clinician.
Diabetes status was determined by either the use of antidiabetic medication, a diagnosis of diabetes, or a fasting glucose concentration of 126.13 mg/dL or greater (to convert to mmol/L, multiply by 0.0555). 29 (link) Dyslipidemia was identified if an individual had a fasting plasma total cholesterol level of 255.21 mg/dL or greater, low-density lipoprotein cholesterol level of 158.30 mg/dL or greater (to convert to mmol/L, multiply by 0.0259), or triglyceride level greater than 150.44 mg/dL (to convert to mmol/L, multiply by 0.0113) or if they were taking statin medication.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!